COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 1263: Articles 12621-12630  | Next

Relationship between support for workers with illness and work functioning impairment in Japan during the COVID-19 pandemic
Yu, I., Tateishi, S., Harada, A., Hno, A., Tsuji, M., Ogami, A., Mori, K., Matsugaki, R., Fujino, Y.
10.1101/2021.09.23.21263920 — Posted: 2021-09-26
Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece
Galanis, P. A., Vraka, I., Siskou, O., Konstantakopoulou, O., Katsiroumpa, A., Moisoglou, I., Kaitelidou, D.
10.1101/2021.09.23.21264009 — Posted: 2021-09-26
The importance of sustained compliance with physical distancing during COVID-19 vaccination rollout
Teslya, A., Rozhnova, G., Pham, T. M., van Wees, D. A., Nunner, H., Godijk, N. G., Bootsma, M. C., Kretzschmar, M. E.
10.1101/2021.09.22.21263944 — Posted: 2021-09-26
Who is at risk of poor mental health following COVID-19 outpatient management?
Hüfner, K., Tymoszuk, P., Ausserhofer, D., Sahanic, S., Pizzini, A., Rass, V., Galffy, M., Böhm, A., Kurz, K., Sonnweber, T., Tancevski, I., Kiechl, S., Huber, A., Plagg, B., Wiedermann, C., Bellmann-Weiler, R., Bachler, H., Weiss, G., Piccoliori, G., Helbok, R., Löffler-Ragg, J., Sperner-Unterweger, B.
10.1101/2021.09.22.21263949 — Posted: 2021-09-26
Social contacts and transmission of COVID-19 in British Columbia, Canada
Ringa, N., Otterstatter, M. C., Iyaniwura, S. A., Irvine, M. A., Adu, P., Janjua, N. Z., David, S., Spencer, M.
10.1101/2021.09.23.21263649 — Posted: 2021-09-26
Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19
Pan, D., Kim, J. W., Nazareth, J., Assadi, S., Bellass, A., Leach, J., Brosnan, J. G., Ahmed, A., Starcevic, F., Sze, S., Martin, C. A., Williams, C. M., Barer, M. R., Sahota, A., Patel, P., Tattersall, A., Cooper, A., Pareek, M., Haldar, P.
10.1101/2021.09.21.21263902 — Posted: 2021-09-26
Neutralizing efficacy of vaccines against the SARS-CoV-2 Mu variant
Miyakawa, K., Jeremiah, S. S., Kato, H., Ryo, A.
10.1101/2021.09.23.21264014 — Posted: 2021-09-26
Assessing the impact of temperature and humidity exposures during early infection stages on case-fatality of COVID-19: a modelling study in Europe
Liang, J., Yuan, H.-Y.
10.1101/2021.09.23.21264017 — Posted: 2021-09-26
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Zeng, B., Gao, L., Zhou, Q., Yu, K., Sun, F.
10.1101/2021.09.23.21264048 — Posted: 2021-09-26 Discussion: Onsite
Evidence of Persisting Autoreactivity in Post-Acute Sequelae of SARS-CoV-2 Infection
Woodruff, M., Walker, T., Truong, A., Han, J., Dixit, A., Ramonell, R., Runnstrom, M., Rudoloph, M., Khosroshahi, A., Lee, F. E.-H., Sanz, I.
10.1101/2021.09.21.21263845 — Posted: 2021-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).